The Haitian proverb, Dèyè mòn, gen mòn (Beyond mountains, more mountains) comes to mind when surveying the current scene in pharma traceability. The industry has been on a long slog to get appropriately barcoded labels on each saleable unit of […]
Read MoreIn an anticipated move, Dassault Systèmes, a French enterprise IT firm (its better-known aviation business is a separate company) will acquire Medidata Solutions, at a 17% premium over the stock price it had before rumors began circulating this spring. Medidata […]
Read MoreAfter the flurry of hype, artificial intelligence is on the rise and enabling a smarter, more efficient and more effective business. Once-scrappy experiments have now matured into high-impact enterprise applications. Many organizations, however, are still unclear about how to build […]
Read MoreAt its annual conference and expo (Palm Desert, CA, March 10-13), the Healthcare Distribution Alliance awarded its Distribution management Award to two innovative projects in pharma distribution: the MediLedger Project, managed by Chronicled, and the Cubixx CT At-Home Clinical Trial […]
Read MoreThe recent FDA call for proposals to demonstrate pharma traceability objectives of the Drug Supply Chain Security Act (DSCSA) has a least one candidate: TraceLink. The company has announced that it will join with an unnamed number of manufacturers, wholesalers, […]
Read MoreThe Drug Supply Chain Security Act (DSCSA) of 2013 specified that FDA should both hold public hearings to gather industry commentary on how the program is to be implemented, and to organize pilot projects to demonstrate the feasibility of industry […]
Read MoreUnlike other providers of electronic prior-authorization (ePA) support, who tend to be focused around the specifications of payer programs, ZappRx offers its support on a disease-specific (and in some cases, manufacturer-specific) basis. Having already set up programs for a variety […]
Read More
Hey! Remember that Nov. 27 DSCSA deadline? The one that required 100% of pharma products to have unique serial numbers embossed on their packaging to go into commercial distribution in the US, on pain of having the products removed from […]
Read More“Prescription digital therapeutics” (PDT) is more than three nice-sounding words bolted together—it is now entering the commercial arena as a new approach to disease management. This week, Sandoz and Pear Therapeutics are officially launching reSET-O, Pear’s branding for an FDA-approved […]
Read MoreAntares Vision S.p.A., one of the leading vendors of traceability technology for the life sciences industry, has agreed to a €70-million investment (about $80 million), representing 12% of the company’s valuation, from the Italian merchant bank Mediobanca. (Technically, Antares Vision […]
Read More